BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32544918)

  • 1. Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center in Relation to Complementary and Alternative Medicine.
    Hack CC; Wasner S; Meyer J; Häberle L; Jud S; Hein A; Wunderle M; Emons J; Gass P; Fasching PA; Egloffstein S; Beckmann MW; Lux MP; Loehberg CR
    Complement Med Res; 2020; 27(6):431-439. PubMed ID: 32544918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center.
    Loehberg CR; Meyer J; Häberle L; Hack CC; Jud S; Hein A; Wunderle M; Emons J; Gass P; Fasching PA; Egloffstein S; Krebs J; Erim Y; Beckmann MW; Lux MP; Wasner S
    Arch Gynecol Obstet; 2020 May; 301(5):1299-1306. PubMed ID: 32274639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an Expert Guided Integrative Therapy Concept in Patients With Breast or Gynecological Cancer During Systemic Therapy.
    Schmidt G; Mathes S; Klein E; Kiechle M; Paepke D
    J Evid Based Integr Med; 2020; 25():2515690X20949444. PubMed ID: 32808558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care.
    Ben-Arye E; Schiff E; Steiner M; Keshet Y; Lavie O
    Int J Gynecol Cancer; 2012 Jan; 22(1):146-53. PubMed ID: 21912265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center Regarding Consensus between the First and Second Opinion and Conformity with the Guidelines.
    Lux MP; Wasner S; Meyer J; Häberle L; Hack CC; Jud S; Hein A; Wunderle M; Emons J; Gass P; Fasching PA; Egloffstein S; Krebs J; Erim Y; Beckmann MW; Loehberg CR
    Breast Care (Basel); 2021 Jun; 16(3):291-298. PubMed ID: 34248471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Predictors for Nonuse of Complementary Medicine among Breast and Gynecological Cancer Patients.
    Paepke D; Wiedeck C; Hapfelmeier A; Karmazin K; Kiechle M; Brambs C
    Breast Care (Basel); 2020 Aug; 15(4):380-385. PubMed ID: 32982648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network.
    Fremd C; Hack CC; Schneeweiss A; Rauch G; Wallwiener D; Brucker SY; Taran FA; Hartkopf A; Overkamp F; Tesch H; Fehm T; Hadji P; Janni W; Lüftner D; Lux MP; Müller V; Ettl J; Belleville E; Sohn C; Schuetz F; Beckmann MM; Fasching PA; Wallwiener M
    Arch Gynecol Obstet; 2017 May; 295(5):1239-1245. PubMed ID: 28331996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beliefs of New Zealand doctors about integrative medicine for cancer treatment.
    Bocock C; Reeder AI; Perez D; Trevena J
    Integr Cancer Ther; 2011 Sep; 10(3):280-8. PubMed ID: 21498472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physicians attitudes towards complementary and alternative medicine in patients with cancer: preliminary report from pediatric and oncology centers].
    Duleba K; Wysocki M; Styczyński J
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1148-54. PubMed ID: 19531841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behaviors of seeking a second opinion from other health-care professionals and the utilization of complementary and alternative medicine in gynecologic cancer patients.
    Tam KF; Cheng DK; Ng TY; Ngan HY
    Support Care Cancer; 2005 Sep; 13(9):679-84. PubMed ID: 16032409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Demand for Integrative Medicine Practices in Breast and Gynecological Cancer Patients.
    Schuerger N; Klein E; Hapfelmeier A; Kiechle M; Brambs C; Paepke D
    Breast Care (Basel); 2019 Mar; 14(1):35-40. PubMed ID: 31019441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies.
    Fasching PA; Thiel F; Nicolaisen-Murmann K; Rauh C; Engel J; Lux MP; Beckmann MW; Bani MR
    Support Care Cancer; 2007 Nov; 15(11):1277-1284. PubMed ID: 17333294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy.
    Drozdoff L; Klein E; Kiechle M; Paepke D
    BMC Complement Altern Med; 2018 Sep; 18(1):259. PubMed ID: 30249217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demand for integrative medicine among women in pregnancy and childbed: a German survey on patients' needs.
    Schürger N; Klein E; Hapfelmeier A; Kiechle M; Paepke D
    BMC Complement Altern Med; 2018 Jun; 18(1):187. PubMed ID: 29907100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and interest in complementary and alternative medicine among college students seeking healthcare at a university campus student health center.
    Nguyen J; Liu MA; Patel RJ; Tahara K; Nguyen AL
    Complement Ther Clin Pract; 2016 Aug; 24():103-8. PubMed ID: 27502809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of COVID-19 fear and anxiety on attitudes towards complementary and alternative medicine use in women with gynecological cancer during the COVID-19 pandemic.
    Uslu-Sahan F; Yesilcınar I; Kurt G; Hancer E; Guvenc G
    J Integr Med; 2023 Jul; 21(4):377-384. PubMed ID: 37353374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary and Alternative Medicine Use in Breast Cancer Patients at a Medical Center in Taiwan: A Cross-Sectional Study.
    Chin CY; Chen YH; Wu SC; Liu CT; Lee YF; Tsai MY
    Integr Cancer Ther; 2020; 19():1534735420983910. PubMed ID: 33372560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer.
    Segev Y; Lavie O; Stein N; Saliba W; Samuels N; Shalabna E; Raz OG; Schiff E; Ben-Arye E
    Support Care Cancer; 2021 Jul; 29(7):4055-4064. PubMed ID: 33404816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitude of employees of a university clinic to complementary and alternative medicine in oncology.
    Trimborn A; Senf B; Muenstedt K; Buentzel J; Micke O; Muecke R; Prott FJ; Wicker S; Huebner J;
    Ann Oncol; 2013 Oct; 24(10):2641-2645. PubMed ID: 23942776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study : Complementary and alternative medicine in oncology.
    Bozza C; Gerratana L; Basile D; Vitale MG; Bartoletti M; Agostinetto E; Russo S; Follador A; De Carlo E; Pella N; Sottile R; Fasola G; Puglisi F
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2029-2047. PubMed ID: 30043280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.